Selective nicotinic receptor consequences in APPSWE transgenic mice

被引:57
作者
Bednar, I
Paterson, D
Marutle, A
Pham, TM
Svedberg, M
Hellström-Lindahl, E
Mousavi, M
Court, J
Morris, C
Perry, E
Mohammed, A
Zhang, X
Nordberg, A
机构
[1] Huddinge Univ Hosp, Div Mol Neuropharmacol, S-14186 Huddinge, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Clin Neurosci Occupat Therapy & Elderly Care, Div Geriatr Med, S-14186 Huddinge, Sweden
[3] Joint MRC Newcastle Univ, Newcastle Gen Hosp, Ctr Dev Clin Brain Aging, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
关键词
D O I
10.1006/mcne.2002.1112
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The nicotinic (nAChRs) and muscarinic (mAChRs) acetylcholine receptors and acetylcholinesterase (AChE) activity were studied in the brains of APP(SWE) transgenic mice (Tg+) and age-matched nontransgenic controls (Tg-) that were between 4 and 19 months of age. A significant increase in the binding of I-125-labeled alpha-bungarotoxin (alpha7 nAChRs) was observed in most brain regions analyzed in 4-month-old Tg+ mice, preceding learning and memory impairments and amylold-beta (Abeta) pathology. The enhanced alpha7 receptor binding was still detectable at 17-19 months of age. Increase in [H-3]cytisine binding (alpha4beta2 nAChRs) was measured at 17-19 months of age in Tg + mice, at the same age when the animals showed heavy Abeta pathology. No significant changes in [H-3]pirenzepine (M1 mAChRs) or [H-3]AFDX 384 (M2 mAChRs) binding sites were found at any age studied. The upregulation of the nAChRs probably reflects compensatory mechanisms in response to Abeta burden in the brains of Tg+ mice.
引用
收藏
页码:354 / 365
页数:12
相关论文
共 56 条
  • [1] β-amyloid peptides as direct cholinergic neuromodulators:: a missing link?
    Auld, DS
    Kar, S
    Quirion, R
    [J]. TRENDS IN NEUROSCIENCES, 1998, 21 (01) : 43 - 49
  • [2] Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein London mutant transgenic mice
    Bronfman, FC
    Moechars, D
    Van Leuven, F
    [J]. NEUROBIOLOGY OF DISEASE, 2000, 7 (03) : 152 - 168
  • [3] Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
    Chapman, PF
    White, GL
    Jones, MW
    Cooper-Blacketer, D
    Marshall, VJ
    Irizarry, M
    Younkin, L
    Good, MA
    Bliss, TVP
    Hyman, BT
    Younkin, SG
    Hsiao, KK
    [J]. NATURE NEUROSCIENCE, 1999, 2 (03) : 271 - 276
  • [4] Nicotinic receptor abnormalities in Alzheimer's disease
    Court, J
    Martin-Ruiz, C
    Piggott, M
    Spurden, D
    Griffiths, M
    Perry, E
    [J]. BIOLOGICAL PSYCHIATRY, 2001, 49 (03) : 175 - 184
  • [5] β-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors:: In vitro and in vivo mechanisms related to Alzheimer's disease
    Dineley, KT
    Westerman, M
    Bui, D
    Bell, K
    Ashe, KH
    Sweatt, JD
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (12) : 4125 - 4133
  • [6] Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein
    Fitzjohn, SM
    Morton, RA
    Kuenzi, F
    Rosahl, TW
    Shearman, M
    Lewis, H
    Smith, D
    Reynolds, DS
    Davies, CH
    Collingridge, GL
    Seabrook, GR
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (13) : 4691 - 4698
  • [7] Frautschy SA, 1998, AM J PATHOL, V152, P307
  • [8] FREEDMAN R, 1993, J NEUROSCI, V13, P1965
  • [9] In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice
    Giacchino, J
    Criado, JR
    Games, D
    Henriksen, S
    [J]. BRAIN RESEARCH, 2000, 876 (1-2) : 185 - 190
  • [10] Suppressed expression of nicotinic acetylcholine receptors by nanomolar β-amyloid peptides in PC12 cells
    Guan, ZZ
    Miao, H
    Tian, JY
    Unger, C
    Nordberg, A
    Zhang, X
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (12) : 1417 - 1433